-
2024-516966-12-00
4
2026-02-13
Alzheimer’s disease
-
2025-522960-34-00
5
2026-02-09
Established cardiovascular disease
-
2024-517397-25-00
1
2026-01-26
B-cell Mediated Autoimmune Diseases
-
2025-521620-29-01
4
2026-01-26
Atopic Dermatitis
-
2025-521686-27-01
4
2026-01-08
Major Depression Disorder (MDD)
-
2024-515172-12-00
4
2025-12-23
Epidermolysis Bullosa
-
2024-513586-39-00
5
2025-12-10
Prostate Cancer
-
2025-521382-27-00
10
2025-12-04
Moderately to Severely Active Crohn's Disease
-
2025-521398-15-00
5
2025-12-04
Immune system diseases
-
2025-521381-10-00
5
2025-12-03
Moderately to Severely Active Ulcerative Colitis
-
2023-503447-33-00
4
2025-11-13
febrile Urinary Tract Infection (fUTI)
-
2025-521405-40-01
11
2025-11-12
Adult patients undergoing tracheal intubation using video laryngoscopy
-
2024-519871-24-00
10
2025-11-11
Breast cancer
-
2024-520190-12-00
5
2025-11-10
Breast Cancer: triple negative breast cancer (TNBC) and hormone recept
-
2024-517131-52-00
5
2025-11-03
Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lym
-
2023-508056-19-00
5
2025-10-02
HER2-Expressing (IHC 3+/IHC 2+), Mismatch Repair Proficient (pMMR), P
-
2025-520672-26-00
9
2025-09-16
Gastrointestinal Neoplasms
-
2024-516982-35-00
5
2025-09-11
Ovarian Cancer
-
2023-506135-14-00
11
2025-09-10
Breast cancer
-
2025-520519-14-00
5
2025-09-03
Atherosclerotic Cardiovascular Disease
-
2024-519331-42-00
5
2025-08-22
pMMR endometrial carcinoma
-
2024-517423-40-00
5
2025-06-23
Metastatic Castration-Resistant Prostate Cancer
-
2024-518360-13-00
1
2025-06-18
HER2-positive metastatic breast cancer
-
2023-510294-34-00
5
2025-06-12
small lymphocytic lymphoma (SLL)